SS-31 (elamipretide): identity and U.S. product authorization

SS-31 is a research name for elamipretide, a peptide with four amino acid residues. ClinicalTrials.gov lists SS-31 among elamipretide’s other names. The FDA label describes its chemical structure and identifies it as a mitochondrial cardiolipin binder. Study record; FDA product label, sections 11 and 12.1.

What the chemical name tells you

The label gives the peptide sequence as D-Arg-2,6-dimethyl-Tyr-Lys-Phe-NH2. It specifies that arginine has the D configuration and the other amino acid residues have the L configuration. These details describe the molecule’s identity. The label also identifies the hydrochloride salt used in the approved product. FDA product label, section 11.

A peptide name, its salt form and a finished product describe different things. The finished product has a defined formulation as well as an active ingredient. A listing that says SS-31 or elamipretide does not, by its name alone, establish that it matches the product described in an FDA approval record. FDA review includes product-specific manufacturing and labeling information. FDA product review information.

Cardiolipin and the mitochondrial membrane

The FDA label describes elamipretide as a cardiolipin binder that localizes to the inner mitochondrial membrane. This identifies a molecular interaction and its location within the cell. It does not establish a general wellness benefit for products advertised under the SS-31 name. FDA product label, section 12.1.

What the U.S. approval covers

The FDA’s 2025 approval list records an elamipretide product approval on September 19, 2025. NDA215244 documents a specific prescription product with a defined authorized use. This authorization does not extend to every compound offered online as SS-31. FDA approval list; FDA product label.

The label records accelerated approval and states that continued approval may depend on a confirmatory trial. It also contains product-specific warnings and precautions. The approval record provides no blanket assurance about an unrelated preparation’s identity or quality. FDA product label, sections 1 and 5; FDA product review information.

Related reading

For the basic vocabulary, read what peptides are. The Peptide Guide includes separate profiles of MOTS-c and humanin. Each compound needs its own evidence and regulatory assessment.

Peptide Labs does not sell SS-31. This information is educational and is not medical advice. Personal medical questions belong with a licensed healthcare professional.

Sources